HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by AustralianSuper Pty Ltd

AustralianSuper Pty Ltd grew its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 118.5% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 35,493 shares of the company's stock after buying an additional 19,247 shares during the period. AustralianSuper Pty Ltd's holdings in HCA Healthcare were worth $14,425,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of HCA. NorthRock Partners LLC increased its position in HCA Healthcare by 17.4% during the first quarter. NorthRock Partners LLC now owns 1,310 shares of the company's stock worth $437,000 after purchasing an additional 194 shares during the last quarter. State of Alaska Department of Revenue increased its position in shares of HCA Healthcare by 0.5% during the first quarter. State of Alaska Department of Revenue now owns 21,490 shares of the company's stock valued at $7,167,000 after acquiring an additional 100 shares during the last quarter. Norden Group LLC acquired a new stake in shares of HCA Healthcare during the first quarter valued at about $597,000. First Trust Direct Indexing L.P. increased its position in shares of HCA Healthcare by 3.8% during the first quarter. First Trust Direct Indexing L.P. now owns 7,854 shares of the company's stock valued at $2,620,000 after acquiring an additional 291 shares during the last quarter. Finally, J.W. Cole Advisors Inc. acquired a new stake in shares of HCA Healthcare during the first quarter valued at about $317,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have recently commented on HCA shares. TD Cowen lowered their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a "buy" rating for the company in a research note on Monday. Cantor Fitzgerald reissued an "overweight" rating and issued a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. Royal Bank of Canada raised their price objective on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an "outperform" rating in a research note on Friday, August 23rd. Wolfe Research upgraded shares of HCA Healthcare to a "strong-buy" rating in a research note on Thursday, August 29th. Finally, UBS Group lifted their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a "buy" rating in a research note on Wednesday, August 14th. Five research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and three have issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $379.11.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of the company's stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company's stock, valued at $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.60% of the stock is owned by insiders.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock traded down $2.35 on Thursday, hitting $358.57. The company's stock had a trading volume of 1,188,174 shares, compared to its average volume of 1,164,341. HCA Healthcare, Inc. has a 52-week low of $223.73 and a 52-week high of $417.14. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The firm has a fifty day moving average price of $394.11 and a 200-day moving average price of $353.54. The company has a market capitalization of $93.91 billion, a P/E ratio of 18.00, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.74%. HCA Healthcare's dividend payout ratio (DPR) is 13.16%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.